Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Mich 48109-5853, USA.
Circ Heart Fail. 2010 Mar;3(2):244-52. doi: 10.1161/CIRCHEARTFAILURE.109.884098. Epub 2010 Jan 8.
Heart transplant centers are generally considered "centers of excellence" for heart failure care. However, their overall performance has not previously been evaluated in a broad population of elderly patients with heart failure, many of whom are not transplant candidates.
We identified >1 million elderly Medicare beneficiaries who were hospitalized for heart failure between 2004 and 2006 at >4500 hospitals. We calculated 30-day risk-standardized mortality rates and standardized mortality ratios as well as 30-day risk-standardized readmission rates and standardized readmission ratios at heart transplant centers and non-heart transplant hospitals using risk-standardization models that the Centers for Medicare & Medicaid Services uses for public reporting. The 30-day risk-standardized mortality rates were lower at heart transplant centers than non-heart transplant hospitals nationally (10.6% versus 11.5%, P<0.001) but were similar at peer institutions offering coronary artery bypass grafting within the same geographical region (10.6% versus 10.6%, P=0.96). The mean standardized mortality ratio for heart transplant centers was 0.9 (SD, 0.1; range, 0.7 to 1.3). No differences were noted in 30-day risk-standardized readmission rates between heart transplant centers and non-heart transplant hospitals nationally (23.6% versus 23.8%, P=0.55). The mean standardized readmission ratio for heart transplant centers was 1.0 (SD, 0.1; range, 0.8 to 1.2).
In elderly Medicare patients with heart failure, heart transplant centers have lower 30-day risk-standardized mortality rates than non-heart transplant hospitals nationally; however, this difference is not present in comparison with peer institutions or for 30-day risk-standardized readmission rates.
心脏移植中心通常被认为是心力衰竭治疗的“卓越中心”。然而,以前尚未在患有心力衰竭的广泛老年人群中评估其整体表现,其中许多患者不是移植候选者。
我们在 2004 年至 2006 年期间在 4500 多家医院确定了超过 100 万患有心力衰竭的老年医疗保险受益人住院。我们使用医疗保险和医疗补助服务中心用于公开报告的风险标准化模型,计算了心脏移植中心和非心脏移植医院的 30 天风险标准化死亡率和标准化死亡率比,以及 30 天风险标准化再入院率和标准化再入院率。全国范围内,心脏移植中心的 30 天风险标准化死亡率低于非心脏移植医院(10.6%比 11.5%,P<0.001),但在同一地理区域内提供冠状动脉旁路移植术的同行机构中则相似(10.6%比 10.6%,P=0.96)。心脏移植中心的平均标准化死亡率比为 0.9(标准差,0.1;范围,0.7 至 1.3)。全国范围内,心脏移植中心与非心脏移植医院之间 30 天风险标准化再入院率无差异(23.6%比 23.8%,P=0.55)。心脏移植中心的平均标准化再入院率为 1.0(标准差,0.1;范围,0.8 至 1.2)。
在患有心力衰竭的老年医疗保险患者中,心脏移植中心的 30 天风险标准化死亡率低于全国范围内的非心脏移植医院;然而,与同行机构或 30 天风险标准化再入院率相比,这种差异并不存在。